Charles River Laboratories | CRL - Ebitda



Charles River Laboratories reported $220.89M in EBITDA for its fiscal quarter ending in June of 2025.


Ebitda Change Date
Agilent USD 466M 14M Jul/2025
Align Technology USD 137.61M 77.61M Mar/2025
Bio-Rad Laboratories USD 467.2M 372.2M Jun/2025
Bruker USD 128.1M 27.1M Jun/2025
Cardinal Health USD 667M 271M Jun/2025
Charles River Laboratories USD 220.89M 2.01M Jun/2025
Cigna USD 2.86B 56M Mar/2025
CVS Health USD 3.58B 1.63B Jun/2025
Danaher USD 1.34B 543M Jun/2025
Dentsply International USD 197M 45M Jun/2025
Elevance Health 3.21B 392M Jun/2025
Galapagos EUR -158708000 177.84M Mar/2025
Hologic USD 334M 26.7M Jun/2025
Humana USD 1.37B 883M Jun/2025
Illumina USD 399M 168M Jun/2025
Incyte USD 581.52M 358.87M Jun/2025
IQVIA Holdings USD 910M 112M Jun/2025
Laboratory Of America USD 633.6M 135.6M Jun/2025
Lonza CHF 1.01B 139M Dec/2024
McKesson USD 1.26B 299M Jun/2025
Merck EUR 1.46B 45M Jun/2025
Mettler Toledo International USD 295.89M 43.87M Jun/2025
Novartis USD 6.17B 339M Jun/2025
Pfizer USD 5.32B 889M Jun/2025
Quest Diagnostics USD 570M 65M Jun/2025
Revvity USD 209.29M 22.24M Jun/2025
Thermo Fisher Scientific USD 3.06B 541M Jun/2025
United Therapeutics USD 436.8M 34.2M Jun/2025
UnitedHealth 6.23B 3.93B Jun/2025
Waters USD 276.28M 74.81M Jun/2025
West Pharmaceutical Services USD 164.8M 43.8M Mar/2025